Abstract:Objective: To summarize the clinical characteristics of SYNGAP1-related epilepsy in children. Methods: Data of 13 patients with SYNGAP1 gene variants diagnosed with epilepsy at Department of Neurology, Beijing Children's Hospital were collected retrospectively from March 2017 to October 2020 and the patients were followed up. The clinical features, electroencephalogram(EEG), brain imaging, gene results and treatment were summarized. Results: Twelve patients were followed up successfully among the 13 patients with SYNGAP1 variants. The last follow-up age was 5 years and 7 months (3 years and 1 month to 9 years).The onset age of seizures was 2 years (4 months to 3 years). Seizure types included eyelid myoclonia with or without absence (9 cases), myoclonic seizure (5 cases), atypical absence (4 cases), suspicious atonic seizures(4 cases),unclassified fall attack (6 cases), and the frequency of seizures varied from several times to more than 100 times per day. Four cases had the mimic phenotype of myoclonic astatic epilepsy. The seizures of 10 cases could be triggered by eating (5 cases), emotion (5 cases), fever (3 cases), voice (2 cases), fatigue (2 cases), etc. Electroencephalography (10 cases) showed interictal generalized or focal epileptiform discharges (9 cases), and atypical aphasia (4 cases), myoclonic seizure (2 cases) and eyelid myoclonic seizure (1 case) were monitored. Of the 12 cases, 9 were added with valproate, all of which were effective (the frequency of seizures reduced>50%). Five cases received combined levetiracetam, in 3 the treatments were effective. To last follow-up, 3 cases were seizure free from 6 months to 1 year and 1 month, but the remaining 7 cases still had seizures, one or several times per day. All 13 cases had developmental retardation (speech ability impaired mostly), 2 cases were severe, 10 cases were moderate, 1 case was mild. The SYNGAP1 gene variants of 13 patients were all de novo, including 12 variants. Among them, 4 were frameshift variants, 4 were nonsense variants, 2 were missense variants and 2 were splice site variants. Conclusions: Patients with SYNGAP1-related epilepsy have an early onset age and many seizure types. The main seizure type is eyelid myoclonia with or without absence, and other seizure types include myoclonic seizure, atypical absence, unclassified fall attack, etc. Valproate is effective in most patients, but seizures in some patients might be intractable. Most patients have developmental delay (mainly moderate and severe), speech ability impaired mostly.

A case with autosomal dominant mental retardation type 5 due to de novo SYNGAP1 variant

[Identification of a novel SYNGAP1 mutation in a child with intellectual disability].

Phenotype and genotype analyses of Chinese patients with autosomal dominant mental retardation type 5 caused by SYNGAP1 gene mutations

Identification and functional characterization of de novo variant in the SYNGAP1 gene causing intellectual disability

Novel variants in AP4B1 cause spastic tetraplegia, moderate psychomotor development delay and febrile seizures in a Chinese patient: a case report

Novel variants of SYNGAP1 associated epileptic encephalopathy: two cases report and literature review

Genotype–Phenotype Correlations in SYNGAP1‐Related Mental Retardation Type 5

Novel SNX13 Frameshift Variant in an Individual with Developmental Delay.

[Correlation of early neurodevelopmental features of children with SYNGAP1 variants and their genotypes]

[Genetic analysis of a child with pachygyria due to variant of ADGRG1 gen]

[Analysis of clinical features and ZBTB18 gene variant in a child with autosomal dominant mental disorder type 22]

Familial SYN1 Pathogenic Mutations Related Neurodevelopmental Disorders in Asian Pediatric Patients

Case Report: A developmental and epileptic encephalopathy 45 due to de novo variant of GABRB1

Case report: Novel NUS1 variant in a Chinese patient with tremors and intellectual disability

Case Report: Whole exome sequencing identifies compound heterozygous variants in the TRAPPC9 gene in a child with developmental delay

[Clinical Characteristics and Gene Analysis of SYNGAP1-related Epilepsy in Children].

A de novo variant in CASK gene causing intellectual disability and brain hypoplasia: a case report and literature review

De novo variants in PHF21A cause intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures: A case report and literature review

Genetic analysis of a child with severe intellectual disability caused by a novel variant in the FERM domain of the FRMPD4 protein

A Novel Composition of Two Heterozygousgfm1mutations in a Chinese Child with Epilepsy and Mental Retardation

A New Case of De Novo Variant C.892c>t (p.arg298trp) in NACC1: A First Case Report from China.